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of high dimension to a follow-up study
Marina Bogomolov and Ruth Heller1
Technion and Tel-Aviv University
Abstract. We consider the problem of identifying whether findings replicate from one
study of high dimension to another, when the primary study guides the selection of hy-
potheses to be examined in the follow-up study as well as when there is no division of roles
into the primary and the follow-up study. We show that existing meta-analysis methods
are not appropriate for this problem, and suggest novel methods instead. We prove that
our multiple testing procedures control for appropriate error-rates. The suggested FWER
controlling procedure is valid for arbitrary dependence among the test statistics within
each study. A more powerful procedure is suggested for FDR control. We prove that this
procedure controls the FDR if the test statistics are independent within the primary study,
and independent or have dependence of type PRDS in the follow-up study. For arbitrary
dependence within the primary study, and either arbitrary dependence or dependence of
type PRDS in the follow-up study, simple conservative modifications of the procedure
control the FDR. We demonstrate the usefulness of these procedures via simulations and
real data examples.
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1 Introduction
In genomics research, it is customary that a primary study is followed by an inde-
pendent study. Reporting results from the primary study, and then reporting the
evidence from the follow-up study that supports these results, gives a sense of the
replicability of the results. For example, findings are informally regarded as replicated
if the p-value for testing a null hypothesis is small in the primary study, and then for
the same hypothesis the p-value is fairly small in the follow-up study.
Many approaches are available for analyzing two or more studies, where the follow-up
studies simply serve to add power. See Hedges and Olkin (1985), Benjamini and Yekutieli
(2005), Skol et al. (2006), and Zeggini et al. (2007), among others. In this work, we
focus on analyzing two studies, where the follow-up study serves to confirm the find-
ings that were identified in the primary study. A formal statistical approach is pro-
posed for evaluating whether results from a primary study were indeed replicated in
a follow-up study.
In observational studies, an association may fail to replicate because the discovered as-
sociation was not the actual effect of a treatment but rather that of bias (Rosenbaum,
2001). However, if the finding is replicated in a different cohort, using different diag-
nostic or laboratory methods, then the association between effect and outcome may
be more convincingly causal. Rosenbaum (2001) gives the example of radiation and
leukemia. Suppose higher rates of leukemia are discovered in a primary study among
radiologists, and in a follow-up study among survivors at Hiroshima and Nagasaki.
Radiation is more convincingly causal if the association discovered was replicated in
the follow-up study, since if radiation was not a cause of leukemia, then higher rates
of leukemia among radiologists would not lead us to expect higher rates of leukemia
among survivors at Hiroshima and Nagasaki. Another example comes from the field of
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genomic research. Genome-wide association studies (GWAS) are observational stud-
ies, and therefore there is always a danger that bias may explain away the discoveries.
Kraft et al. (2009) note that for common variants, the anticipated effects are modest
and very similar in magnitude to the subtle biases that may affect genetic association
studies - most notably population stratification bias. For this reason, they argue that
it is important to see the association in other studies conducted using a similar, but
not identical, study base.
It is common practice that interesting findings in a primary GWA study are inves-
tigated in another study, and the interesting results of both studies are reported
(Lander and Kruglyak, 1995). For example, to discover association between single-
nucleotide polymorphisms (SNPs) and hippocampal volume, Bis et al. (2012) tested
2.5× 106 SNPs in a primary study, and only a handful of SNPs in promising loci in a
follow-up study. Bis et al. (2012) forwarded a SNP for replication if the SNP p-value
in the primary study was below 4×10−7, corresponding to one expected false positive
if all SNPs are not associated with hippocampal volume. They viewed the SNP as
containing evidence of replication if its p-value in the follow-up study was below 0.01,
which is the Bonferroni threshold when 5 hypotheses are simultaneously tested at the
0.05 family-wise error rate (FWER). Their approach selects hypotheses for follow-up
based on suggestive evidence (Lander and Kruglyak, 1995), and corrects for multi-
plicity only in the follow-up study when discussing evidence of replicability. Another
naive approach is the following: apply a multiple testing procedure within each study
separately, and declare as replicated the common findings. This approach will lead
to declaring SNPs that were found to be associated with the disease in the primary
study as well as in the follow-up study as the discoveries of interest. If there was
no danger that a multiple testing procedure produces false positives, then this naive
approach would have been appropriate. However, multiple testing procedures have a
non-zero probability of producing false positives, unless they have no power. There-
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fore, an approach that provides control over false positives in each study separately,
does not guarantee control over false positives for evaluating whether the results were
replicated. Figure 3, left panel, shows that the FDR level can be as high as one when
naively declaring results as replicated if they were discovered by applying an FDR
controlling procedure at the nominal 0.05 level separately in each study. Moreover,
reducing the nominal 0.05 level does not resolve the problem, see Remark 3.1.
The paper is organized as follows. Section 2 gives the notation and review. Section 3
suggests novel multiple testing procedures for replicability analysis, when the primary
study guides the selection of hypotheses to be examined in a follow-up study. Section
4 considers the setting where there is no division of roles into a primary and a follow-
up study. In Section 5, we revisit the example of Bis et al. (2012). We also analyze
an additional GWAS study, and show additional examples from the GWAS simulator
HAPGEN2 (Su et al., 2011). Section 6 describes a simulation study, and Section 7
gives some final remarks.
2 Notation, Goal, and Review
Consider a family of m elementary null hypotheses H1, . . . , Hm. These elementary
null hypotheses, or a subset thereof, are tested in each of two independent studies.
Let hij be the indicator of whether Hj is false in study i. The pair of indicators
(h1j , h2j) identifies four possible settings for each j,
(h1j , h2j) =

(0, 0) if Hj is true in both studies,
(1, 0) if Hj is false in the primary study but true in the follow-up study,
(0, 1) if Hj is true in the primary study but false in the follow-up study,
(1, 1) if Hj is false in both studies.
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The set of indices {1, . . . , m} of the elementary null hypotheses may be divided into
four (unknown) subsets I00 ∪ I10 ∪ I01 ∪ I11 = {1, . . . , m}, where each index j is in
exactly one of the four subsets, defined as follows: I00 = {j : (h1j , h2j) = (0, 0), j ∈
{1, . . . , m}}; I10 = {j : (h1j , h2j) = (1, 0), j ∈ {1, . . . , m}}; I01 = {j : (h1j, h2j) =
(0, 1), j ∈ {1, . . . , m}}; I11 = {j : (h1j , h2j) = (1, 1), j ∈ {1, . . . , m}}.
Definition 2.1. The no replicability null hypothesis for elementary hypothesis Hj is
HNR,j : (h1j , h2j) ∈ {(0, 0), (0, 1), (1, 0)}.
By definition, HNR,j is false if and only if the elementary null hypothesis Hj is
false in both studies considered. In the family of m composite null hypotheses
HNR,1, . . . , HNR,m, the sets of indices of true and false null hypotheses are I00∪I01∪I10
and I11 respectively. Our goal is to discover as many indices from I11 as possible, i.e.
true positives, while controlling for the number of discoveries from I00 ∪ I01 ∪ I10, i.e.
false positives.
Let pij be the p-value for the jth SNP in study i, for i = 1, 2. Since the studies are in-
dependent, the p-values are independent across studies. However, the p-values within
each study may be dependent. Inequality x ≥ y for vectors x and y is understood
componentwise.
Remark 2.1. In a typical meta-analysis (Hedges and Olkin, 1985), the goal is to
discover as many indices from I01 ∪ I10 ∪ I11 as possible, while controlling for the
number of discoveries from I00. Had we known, and had it been true, that I01 = ∅ and
I10 = ∅, then the typical methods for meta-analysis could serve to discover replicable
findings. However, it is not known in practice whether I01 and I10 are empty sets, and
they need not be empty when the follow-up study is different, in at least one aspect
of design, from the primary study. Therefore, typical meta-analysis methods are not
4
appropriate when the aim is to discover hypotheses with indices in I11, treating all
discoveries from I01 and I10, in addition to I00, as false discoveries.
2.1 The partial conjunction approach
In Benjamini et al. (2009) the partial conjunction approach (Benjamini and Heller,
2008) has been suggested for replicability analysis when n ≥ 2 studies are available
that examine the same problem. When exactly two studies are available, the pro-
cedure in Benjamini et al. (2009) amounts to applying the Benjamini-Hochberg false
discovery rate (FDR) controlling procedure (Benjamini and Hochberg, 1995), hence-
forth referred to as the BH procedure, on the maximum of the two study p-values.
However, this procedure may be too conservative, making it practically very difficult
to discover false no replicability null hypotheses.
As an example, suppose there is an original GWA study that examines the association
of 106 SNPs with a phenotype. Now suppose 200 promising SNPs were selected to
be examined in a follow-up study. If a SNP has a p-value of 0.025/106 in the first
study, and of 0.025/200 in the second study, then the maximum p-value is 0.025/200.
The BH procedure will, most probably, not reject the no replicability null hypothesis
for a SNP with maximum p-value of 0.025/200, since this maximum p-value is not
strong enough evidence when faced with 106 hypotheses, out of which most of the
hypotheses are true no replicability null hypotheses. The alternative procedures we
suggest in Sections 3 and 4 will view the evidence from this SNP as strong enough
for it to be considered a replicated finding.
5
3 Replicability analysis with a primary and a follow-
up study
For the family of m no replicability null hypotheses HNR,1, . . . , HNR,m, we consider
two relevant error measures: the probability that at least one no replicability null
hypothesis is falsely rejected, i.e. the FWER, and the expected fraction of false
rejections out of all rejections of no replicability null hypotheses, that is the FDR.
Procedure 3.1. The two stage FWER controlling procedure for testing the family of
no replicability null hypotheses with parameters (α1, α), where 0 < α1 < α < 1:
1. Let R1 be the set of indices of elementary hypotheses that are selected for testing
in a follow-up study based on the data from the primary study.
2. Apply a FWER controlling procedure at level α1, using the data from the pri-
mary study only, on the family of null hypotheses H1, . . . , Hm, and let Rp ⊆
{1, . . . , m} be the set of indices of rejected hypotheses. Apply a FWER con-
trolling procedure at level α− α1, using the data from the follow-up study only,
on the family of selected null hypotheses {Hj : j ∈ R1}, and let Rf ⊆ R1 be
the set of indices of rejected hypotheses. Then the set of indices of rejected no
replicability null hypotheses is Rf ∩Rp.
Theorem 3.1. For two independent studies, Procedure 3.1 controls the FWER at
level α for the family of no replicability null hypotheses HNR,1, . . . , HNR,m.
Proof. Let Vp =
∑
j∈Rp
(1 − h1j) and Vf =
∑
j∈Rf
(1 − h2j) be the number of true
elementary null hypotheses rejected, respectively, in the primary study and in the
follow-up study. Then
FWER ≤ E(I[Vp + Vf > 0]) ≤ E(I[Vp > 0]) + E(E(I[Vf > 0]|p1)) ≤ α1 + α− α1 = α,
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where the last inequality follows from the fact that Vf is independent of the data
from the primary study, and that in both studies a FWER controlling procedure is
applied.
Using Bonferroni in Procedure 3.1 amounts to rejectingHNR,j if (p1j, p2j) ≤ (α1/m, (α−
α1)/|R1|), for j ∈ R1. Alternatively, the results can be reported in terms of Bonferroni-
replicability adjusted p-values pBonf−REPadjj = max (mp1j/c, |R1|p2j/(1− c)), where
c = α1/α. Procedure 3.1 using Bonferroni is equivalent to rejecting all hypotheses
with Bonferroni-replicability adjusted p-values at most α.
The selection rule affects the power of Procedure 3.1. A natural choice for a selection
rule is the set of rejected hypotheses by the FWER controlling procedure at level
α1 on the primary study p-values, since the set of indices of rejected no replicability
null hypotheses is a subset of this set. A rule that selects by the FWER controlling
procedure at level α is not as good, since any additional hypotheses selected will not
be rejected but will result in a more severe multiple testing problem for the follow-up
study. The choice of α1 also affects the power of Procedure 3.1. We observed in
simulations (Supplementary Material) that although the optimal α1 varies with effect
size, the power function is quite flat as long as α1/α is not too close to zero or one.
In many modern applications, controlling the FWER is unnecessary and results in
overly conservative inferences. In genomics research, it is often enough to guaran-
tee FDR control, see Storey and Tibshirani (2003) and Reiner et al. (2003), among
others.
Procedure 3.2. The two stage FDR controlling procedure for testing a family of no
replicability null hypotheses with parameters (q1, q), where 0 < q1 < q < 1:
1. Let R1 be the set of indices of elementary hypotheses that are selected for testing
in a follow-up study based on the data from the primary study. Let R1 = |R1|
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be the cardinality of this set.
2. Let
R2 , max
{
r :
∑
j∈R1
I
[
(p1j, p2j) ≤
(
rq1
m
,
r(q − q1)
R1
)]
= r
}
.
Then the set of indices of rejected no replicability null hypotheses is
R2 =
{
j : (p1j , p2j) ≤
(
R2q1
m
,
R2(q − q1)
R1
)
, j ∈ R1
}
.
The results of Procedure 3.2 can be reported in terms of FDR-replicability adjusted
p-values. Let c = q1/q,
Zj = max
(
mp1j
c
,
R1p2j
1− c
)
, j ∈ R1, (3.1)
and let Z(1) ≤ . . . ≤ Z(R1) be the sorted Z-values. Then the ith largest FDR-
replicability adjusted p-value is
pREPadj(i) = minj≥i
Z(j)
j
. (3.2)
Procedure 3.2 with parameters (q1, q) = (cq, q) is equivalent to rejecting all no repli-
cability null hypotheses with FDR-replicability adjusted p-values at most q.
Definition 3.1. A valid selection rule for step 1 of Procedure 3.2 satisfies the follow-
ing condition: for any j ∈ R1, fixing all the p-values except for p1j and changing p1j
so that H1j is still selected, will not change the set R1.
It is easy to see that this condition is satisfied if R1 contains the smallest fixed
number of p-values, all hypotheses with p-value below a given threshold, or if R1
contains the rejected indices from a BH procedure on the p-values from the pri-
mary study. Adaptive FDR procedures on the p-values from the primary study, e.g.
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Benjamini and Hochberg (2000), Storey et al. (2004), Benjamini et al. (2006), and
Blanchard and Roquain (2009), are non-valid selection rules.
Theorem 3.2. If all the p-values are jointly independent and the selection rule in
step 1 of Procedure 3.2 is a valid selection rule, then Procedure 3.2 controls the FDR
at level q for the family of no replicability null hypotheses HNR,1, . . . , HNR,m.
See Appendix A for the proof.
The selection rule and the choice of q1 affect the power of Procedure 3.2. A natural
choice for a selection rule is the set of rejected hypotheses by the BH procedure at level
q1 on the primary study p-values, since the set of indices of rejected no replicability
null hypotheses is a subset of this set. A rule that selects by the BH procedure at
level q is not as good as the rule at level q1, since any additional hypotheses selected
will not be rejected, but will result in more severe thresholds on the follow-up study
p-values. In Figure 4 we showed in a simulated example that the BH procedure at
level q1 was very close to selecting the optimal number of hypotheses for follow-up.
We recommend using it when there are no additional constraints that require choosing
only a small number of hypotheses for follow-up. The optimal choice of q1 depends
on |I00|, |I01|, |I10|, |I11|, and the non-null distribution of the p-values, and therefore
guidelines for choosing q1 are application specific. In simulated GWAS in Section 5
the choice of q1 had little effect on the average number of discoveries.
Theorem 3.2 assumes independence of the p-values within each study as well as across
the studies. However, the assumption of independence among the p-values within
each study may not be realistic in many applications. Particularly, in GWAS there
is dependency across the SNPs, therefore the p-values within each study may be
dependent. Benjamini and Yekutieli (2001) proved that the BH procedure controls
the FDR when the p-values have a special dependency called PRDS.
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Definition 3.2. (Benjamini and Yekutieli, 2001) The set of p-values P1, . . . , PM has
property PRDS if for any increasing set D, and for each true null hypothesis i,
Pr((P1, . . . , PM) ∈ D|Pi = p) is nondecreasing in p .
If the p-values are independent in the primary study, yet have property PRDS in
the follow-up study, Theorem S3.1 in the Supplementary Material shows that the
result in Theorem 3.2 holds. For arbitrary dependence among the p-values in the
primary study, a modification of the cut-off level of Procedure 3.2 will guarantee that
the FDR is controlled at the nominal level. The most severe modification, that will
guarantee FDR control for any valid selection rule, is to apply Procedure 3.2 with
the modification in item 1 of Theorem 3.3 below. However, in item 2 of Theorem
3.3 we show that the modification factor may be smaller than
∑m
i=1 1/i ≈ logm if
the selected hypotheses for follow-up are a subset of the hypotheses with primary
study p-values below a fixed cut-off t. For example, in GWAS it is common to
select hypotheses with primary study p-values below 1/m, where m is the number
of hypotheses in the primary study (Lander and Kruglyak, 1995). If t ≥ q1
1+
∑m−1
i=1
1
i
,
then the modification in item 1 of Theorem 3.3 cannot be improved. However, if
t < q1
1+
∑m−1
i=1
1
i
, then the modification in item 2 of Theorem 3.3 is less conservative
than the modification in item 1. For typical values of q1 (e.g. q1 ∈ [0.005, 0.045]) and
large m, the threshold t will often be below q1
1+
∑m−1
i=1
1
i
, and therefore item 2 may be
useful in applications. Note, moreover, that if t ≤ q1/m, then item 2 of Theorem 3.3
states that no modification is required, so for a valid selection rule which selects a
subset of the set of hypotheses with primary study p-values below t, where t ≤ q1/m,
Procedure 3.2 is valid for any form of dependency among the p-values in the primary
study.
Theorem 3.3. Assume that the follow-up study p-values have property PRDS, and
are independent of the p-values in the primary study. Then Procedure 3.2 controls
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the FDR at level q for the family of no replicability null hypotheses HNR,1, . . . , HNR,m
if the selection rule used in step 1 of Procedure 3.2 is a valid selection rule, and the
expressions in step 2 of Procedure 3.2 are modified as follows:
1. In the terms rq1/m and R2q1/m only, q1 is replaced by q˜1 = q1/(
∑m
i=1 1/i).
2. In the terms rq1/m and R2q1/m only, q1 is replaced by q˜1, where
q˜1 = max{x : x(1 +
⌈tm/x−1⌉∑
i=1
1/i) = q1},
if only hypotheses with primary study p-values at most a fixed threshold t are
considered for follow-up, i.e. R1 ⊆ {j ∈ {1, . . . , m} : P1j ≤ t}, where t <
q1
1+
∑m−1
i=1
1
i
.
See Supplementary Material for the proof, as well as for additional results under
dependency. Specifically, Theorem S3.2 in the Supplementary Material shows that in
the more general setting of arbitrary dependence among the follow-up study p-values,
it is also necessary to replace (q−q1) with (q−q1)/(
∑R1
i=1 1/i) in the terms r(q−q1)/R1
and R2(q − q1)/R1 in expression 2 of Procedure 3.2. These results are similar to the
result in Benjamini and Yekutieli (2001) for the BH procedure in their Theorem 1.3.
Remark 3.1. Benjamini and Yekutieli (2005) proved in their Proposition 3 that the
procedure that applies the BH procedure at level q1 on the primary study p-values, and
the BH procedure at level q − q1 on the follow-up study p-values, controls the FDR
at level q1(q − q1) < q on the family of global null hypotheses, HG1, . . . , HGm, where
HGj : (h1j , h2j) = (0, 0). However, on the family of no replicability null hypotheses,
HNR,1, . . . , HNR,m, the FDR of this procedure may be higher than the nominal level
q. The key difference between Procedure 3.2 and such a two stage procedure, is the
requirement that the two p-values from a selected hypothesis have to simultaneously
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be smaller than two thresholds. In an extreme scenario where all hypotheses are
from I10 or I01, and the p-values from false null hypotheses are zero, the two stage
procedure may have an FDR of one, as follows. The BH procedure on the primary
study p-values will reject all hypotheses from I10 but also few from I01 (when |I01|
and |I10| are large enough), and the hypotheses from I01 will be rejected by the BH
procedure on the follow-up study p-values, resulting in an FDR of one. However,
Procedure 3.2 will have an FDR level below q. To see this, note that in order to
reject a no replicability null hypothesis by Procedure 3.2, the p-value of the Simes test
(Simes, 1986) for the intersection of the elementary hypotheses indexed by I01, using
the data from the primary study, has to be below q1, or the Simes test p-value for
the intersection of elementary hypotheses indexed by I10 ∩ R1, using the data from
the follow-up study, has to be below q − q1. Therefore, the probability of rejecting at
least one no replicability null hypothesis, which coincides with the FDR since all no
replicability null hypotheses are true, is at most q. See Figure 3, right panel, for a
more realistic simulated example.
4 Replicability analysis with no division into pri-
mary and follow-up studies
Consider now a situation where both studies are available before the analysis. If
some of the elementary hypotheses are examined in only one of the studies, then
these hypotheses are not considered for replicability analysis. In this setting, there
is no primary study and follow-up study. We propose the following generalization of
Procedure 3.2, that can be tuned to treat the two studies symmetrically. Without
loss of generality, we label the studies as study one and study two.
Procedure 4.1. The generalized two stage procedure for testing a family of no
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replicability null hypotheses with parameters (w1, q1, q), where 0 ≤ w1 ≤ 1 and
0 < q1 < q < 1:
1. Apply Procedure 3.2 with parameters (w1q1, w1q) with study one as the primary
study and study two as the follow-up study. Denote the set of indices of rejected
no replicability null hypotheses by R12,w1q.
2. Reverse the roles of study one and study two. Apply Procedure 3.2 with parame-
ters ((1−w1)q1, (1−w1)q). Denote the set of indices of rejected no replicability
null hypotheses by R21,(1−w1)q.
3. The set of indices of rejected no replicability null hypotheses isR12,w1q∪R21,(1−w1)q.
Theorem 4.1. Procedure 4.1 controls the FDR at level q for the family of no repli-
cability null hypotheses HNR,1, . . . , HNR,m if all p-values are jointly independent and
the selection rule in step 1 of Procedure 3.2 is a valid selection rule.
See Appendix C for the proof.
Choosing w1 = 1 results in Procedure 3.2, where study one has the role of the primary
study and study two has the role of the follow-up study. Similarly, choosing w1 = 0
results in Procedure 3.2 with the roles of study one and study two reversed. The
choice 0 < w1 < 1 reflects the similarity of Procedure 4.1 to Procedure 3.2 in the
following way: when w1 is close to one (zero), Procedure 4.1 gives similar results to
Procedure 3.2 with study one (two) as the primary study. The choice w1 = 0.5 results
in a variant of Procedure 3.2 that is symmetric with respect to both studies.
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Table 1: The p-values of SNPs from the primary and follow-up studies, from Table
1 of Bis et al. (2012) (columns 3-4), and the FDR-replicability adjusted p-values for
various choices of c = q1/q (columns 5-7).
Locus Gene Primary Follow-up Bonferroni-replicability adjusted p-values
study study c = 0.2 c = 0.5 c = 0.8
2q24 DPP4 5.2× 10−8 0.7 1.0000 1.0000 1.0000
9q33 ASTN2 1.0× 10−7 0.2 1.0000 0.5000 0.3125
12q14 MSRB3 5.5× 10−9 0.002 0.06875 0.0275 0.0172
WIF1 2.2× 10−8 0.0007 0.2750 0.1100 0.0688
12q24 HRK 4.8× 10−8 5.8× 10−5 0.6000 0.2400 0.1500
5 GWAS examples
In this section we demonstrate the suggested methods on two real data examples
and on a GWAS simulation. A replicability analysis with FWER control is carried
out for the first example, that has only five hypotheses in the follow-up study. A
replicability analysis with FDR control is carried out for the second example, that
has 126 hypotheses in the follow-up study. Finally, in order to examine the robustness
of procedure 3.2 for GWAS type dependency, examples were simulated that retained
the dependencies in the data that occur in GWAS.
Example 1. We reproduce in Table 1, columns 1-4, a subset of the columns of
Table 1 of results of Bis et al. (2012). We added in columns 5-7 the Bonferroni-
replicability adjusted p-values for c = q1/q ∈ {0.2, 0.5, 0.8}. Procedure 3.1 with
parameters (q1, q) = (0.025, 0.05) or (q1, q) = (0.04, 0.05) identified the SNP near
MSRB3 as having replicated association with the phenotype. The choice of c should
be made prior to analysis, and the choice c = 0.8 may be preferred over c ≤ 0.5 when
it is believed that the power to detect an association in the primary study using a
threshold of order 1/(2.5× 106) is smaller than the power to detect an association in
the follow-up study using a threshold of order 1/5.
14
Example 2. To discover associations between SNPs and Crohn’s disease (CD),
Barrett et al. (2008) examined 635,547 SNPs on 3230 cases and 4829 controls of
European descent, collected in three separate studies: NIDDK4, WTCCC5, and a
Belgian-French study. The primary study p-values in this example are the meta-
analysis p-values from the combined data from the three studies. Only hypotheses
with primary study p-values below 5× 10−5 were considered for follow-up. Although
526 SNPs met the selection criterion, only a subset of 126 SNPs were followed up.
These 126 p-values were the smallest two p-values in 63 distinct regions, so the selec-
tion rule is a valid selection rule. Procedure 3.2 with (q1, q) = (0.04, 0.01) identified
36 SNPs. In Appendix D, Table 5 shows the p-values from the primary and follow-up
studies, as well as the FDR-replicability adjusted p-values for the choice c = 0.8, for
these 36 replicability discoveries. Since the p-values are not independent within each
study, a more conservative analysis approach is to modify the cut-offs as suggested
by Theorem 3.3. Assuming PRDS type dependency in the follow-up study, item 1 of
Theorem 3.3 suggests using q˜1 = 0.04/(
∑635,547
i=1 1/i) = 0.0029 for the primary study
cut-offs, while the follow-up study cut-offs remain unchanged. The modified proce-
dure identified 21 SNPs. Column 7 of Table 5 shows the FDR-replicability adjusted
p-values for the choice c = 0.8, where the adjustment is made as described in expres-
sions (3.1) and (3.2), with p1j replaced by p˜1j = (
∑635,547
i=1 1/i)p1j = 13.94 × p1j , j =
1, . . . , 635, 547. Since the SNPs considered for follow-up were only SNPs with pri-
mary study p-values below 5 × 10−5, one could use a less conservative procedure
suggested in item 2 of Theorem 3.3, with q˜1 = 0.0038, where 0.0038 is the solution
to 0.04 = x(
∑⌈635,547×5×10−5/x−1⌉
i=1 1/i+ 1). This procedure resulted in 23 replicability
discoveries. The latter procedure is the recommended procedure, if the investigator
is not willing to assume that Procedure 3.2 is robust to deviations from independence
within the primary study. However, simulations in the next example suggest that for
the type of dependencies that occur in GWAS, Procedure 3.2 may actually be con-
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servative. We come back to the issue of robustness of Procedure 3.2 in the Discussion
Section 7.
GWAS simulation example. We simulated two GWAS from the simulator HAP-
GEN2 (Su et al., 2011). The two studies were generated from two samples of the
HapMap project (The International HapMap Consortium, 2003), a sample of 165
Utah residents with Northern and Western European ancestry (CEU), and a sample
of 109 Chinese in Metropolitan Denver, Colorado (CHD). In the CEU and CHD pop-
ulations, respectively, 34 and 38 SNPs were set as disease SNPs with an increased
multiplicative relative risk of 1.2, and 18 of the disease SNPs were common to both
populations. Each study contained 4500 cases and 4500 referents. The linkage dise-
quilibrium (LD) across SNPs, as measured for the samples in the HapMap project,
was retained. Due to LD, the number of SNPs associated with the phenotype in each
study was larger than the number of disease SNPs. In order to identify the SNPs in
each study that are truly associated with the phenotype, the simulation of 4500 cases
and 4500 controls from the population was repeated 11 times, and 11 p-values were
produced per SNP. SNPs with Fisher’s combined p-value (Loughin, 2004) below the
Bonferroni threshold were considered to be truly associated with the disease. Our
ground truth included 1355 and 1010 SNPs associated with the disease in the CEU
and in the CHD population, respectively, out of which 274 SNPs were associated with
the disease in both populations.
As a standard preprocessing step, we removed SNPs with minor allele frequency
below 0.05, and thus the number of SNPs in the analysis was reduced from 1,387,466
to 887,362, on average, for the 11 pairs of studies. Our selection rule for Procedure
4.1 with parameters (w1, q1, q) was the BH procedure at level w1q1 when the primary
study was the CEU study, and at level (1 − w1)q1 when the primary study was the
CHD study, since the potential set of SNPs to be discovered as having replicated
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associations is at most the set of SNPs that are discovered by the BH procedure (as
discussed in Section 3). Table 2 presents the average number of replicated findings, as
well as the average false discovery proportion (FDP) for the methods compared. The
standard error (SE) is presented in parentheses. From rows 1 and 2 we see that if there
is no division into primary and follow-up studies, then the symmetric Procedure 4.1
discovers more SNPs with replicated associations than the BH procedure on maximum
p-values, while maintaining a low FDP. From rows 3-5, and 6-8, we see that the choice
of which study was the primary study had a large effect on the average number of
discoveries, and the choice of q1 mattered little.
Table 2: For 4500 cases and 4500 referents in both studies, the average number of
associated and disease SNPs discovered (SE), and the average FDP (SE), for different
procedures. The selection rule for Procedure 4.1 was the BH procedure at level w1q1
when the CEU study was the primary study, and at level (1− w1)q1 when the CHD
study was the primary study.
Procedure # Replicated findings FDP
associated SNPs (SE) disease SNPs (SE) (SE)
BH on maximum p-values 29.182 (3.205) 7.364 (0.432) 0.000 (0.000)
4.1 with w1 = 0.5, q1 = 0.025, q = 0.05 77.727 (6.378) 11.455 (0.366) 0.011 (0.005)
4.1 with w1 = 1, q1 = 0.01, q = 0.05 74.091 (6.748) 10.364 (0.310) 0.012 (0.006)
4.1 with w1 = 1, q1 = 0.025, q = 0.05 76.091 (6.221) 10.727 (0.359) 0.012 (0.005)
4.1 with w1 = 1, q1 = 0.04, q = 0.05 69.545 (5.745) 10.818 (0.352) 0.009 (0.005)
4.1 with w1 = 0, q1 = 0.01, q = 0.05 35.545 (4.575) 7.364 (0.607) 0.008 (0.008)
4.1 with w1 = 0, q1 = 0.025, q = 0.05 41.455 (5.294) 8.273 (0.469) 0.007 (0.007)
4.1 with w1 = 0, q1 = 0.04, q = 0.05 42.273 (4.158) 8.545 (0.312) 0.000 (0.000)
From the last column in Table 2 we see that the average FDP was far below 0.05,
suggesting that the procedures are conservative. This conservatism can be alleviated if
the following oracle information were known: the fraction of SNPs with no association
with the phenotype in both studies, f00, and with association with the phenotype only
in the follow-up study, f01. Then it was possible to perform Procedure 4.1 at level
(w1, q
′, 2q′), where q′ is the solution to f00(q
′)2+(f01+1)q
′ = q for w1 ∈ {0, 1}, and the
solution to f00(0.5q
′)2 + (f01 + 1)0.5q
′ = 0.5q for w1 = 0.5, with the same guarantee
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of FDR control at level q, as follows from Appendix B. Specifically, in our simulation
f00 = 0.9990, f01 = 0.00036 on average, after preprocessing. For FDR control at level
q = 0.05, on average q′ = 0.048 for w1 = 0, 1 and q
′ = 0.049 for w1 = 0.5. Table 3
shows the average FDP and average number of rejections for Procedure 4.1 with and
without the oracle. Although the average FDP is higher with the oracle, it is still
below the nominal 0.05 level for two main reasons. First, our simulation preserves the
LD pattern of the SNPs, and thus the p-values within each study are not independent.
Second, the upper bound of f00(q
′)2 + (f01 + 1)q
′ is not a tight upper bound for the
actual FDR level. A tighter oracle upper bound requires knowing the expectation
of |R1 ∩ I10|/|R1|, and this bound is tight if the non-null effect sizes in I10 ∪ I01 are
extremely large.
Table 3: The average FDP and average number of rejections for Procedure 4.1 with
and without the oracle, for FDR control at level 0.05.
FDP # Replicated findings
Oracle (q1, q) = (0.025, 0.05) Oracle (q1, q) = (0.025, 0.05)
w1 = 0.5 0.023 0.011 90 78
w1 = 1 0.023 0.012 85 76
w1 = 0 0.029 0.007 50 41
For the two studies from the CEU and CHD populations, a meta-analysis was per-
formed by first combining the SNP p-values using Fisher’s combining method, and
then applying the BH procedure at level 0.05 on the combined p-values. The average
number of SNPs associated with the disease in at least one study was 393, while less
than 80 SNPs were discovered to have replicated associations (Table 2). The two
main reasons for discovering more SNPs in a typical meta analysis are as follows.
First, the simulation setting contained five times more associated SNPs than SNPs
with replicated associations. Second, for a SNP with a replicated association, the
power to detect that the association is replicated is lower than the power to detect
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that there is an association in at least one study. The discovered SNPs with replicated
associations were a subset of the discovered associated SNPs, but their meta-analysis
p-values were not ranked smallest among all meta-analysis p-values (not shown). Im-
portantly, the discoveries from the meta-analysis could not serve as evidence towards
replicability, since while the average fraction of SNPs with no association in both
studies among the meta-analysis discoveries was 0.06, the average fraction of SNPs
with no replicated association among the meta-analysis discoveries was 0.78.
6 A simulation study
The goal of the simulations was threefold. First, to investigate the effect of the
choice of q1 and w1 on the power of Procedures 3.2 and 4.1. Second, to compare
these procedures to the alternative of applying BH on the maximum p-values, i.e.
the partial conjunction approach when exactly two studies are analyzed. Third, to
investigate the effect of the selection rule on the power of the procedures.
The procedures compared were (1) the BH procedure at level 0.05 on maximum p-
values; (2) Procedure 4.1 with w1 ∈ {0, 0.5, 1}, c = q1/q ∈ {0.1, 0.2, . . . , 0.9}, and
q = 0.05; and (3) the naive (BH-i, BH-j) procedure, i, j ∈ {1, 2}, i 6= j, which
applies the BH procedure at level 0.05 on the p-values of study i, and separately on
the p-values of study j for the hypotheses that were rejected in study i, and declares
hypotheses rejected in both studies as false no replicability null hypotheses; (4) the
oracle Procedure 3.2 with parameters (q1, q) = (q
′, 2q′), where q′ was the solution to
|I00|
m
(q′)2+
(
|I01|
m
+ 1
)
q′ = 0.05. This oracle procedure controls the FDR at level 0.05,
see Appendix B for a proof.
The p-values were generated independently as follows. For Hj , j = 1, . . . , m, P1j =
1 − Φ
(
X1j
σ1
)
and P2j = 1 − Φ
(
X2j
σ2
)
, where X1j ∼ N(µ1j, σ21) and X2j ∼ N(µ2j , σ22).
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We let µij = 0 · (1 − hij) + µi · hij , where i ∈ {1, 2}, and µi ∈ {0.5, 1, . . . , 5}. We
set m = 1000, and fij = |Iij|/m for i, j ∈ {0, 1} as follows: f00 = 0.9, f11 = 0.1;
f00 = 0.9, f01 = f10 = 0.025, f11 = 0.05; f01 = f10 = 0.5; f00 = 0.8, f01 = f10 = 0.1.
The standard deviations σ1 and σ2 were either fixed values σi ∈ {0.3, 1}, i ∈ {1, 2},
or reflected the fraction of sample size allocated to the first study: σ1 = σ/
√
ζN ,
σ2 = σ/
√
(1− ζ)N , σ = 10, ζ ∈ {0.1, 0.2, . . . , 0.9}, N = 1000.
The simulation results were based on 1000 repetitions. The FDR was estimated
by averaging the FDP. The average power was estimated by the average number of
rejected false no replicability null hypotheses, divided by mf11.
6.1 Simulation results
As expected from our theoretical results, in all the settings considered the estimated
FDR was below 0.05 for all procedures but the naive (BH-i, BH-j) procedure. The
SE of the estimated FDR and power were of the order of 10−3 for all procedures under
all configurations considered.
Figure 1 compares the power of the BH procedure on maximum p-values, (1) above,
and Procedure 4.1 with w1 ∈ {0, 0.5, 1}, q1 ∈ {0.01, 0.025, 0.04}, (2) above, in a
configuration with parameters σ1 = 0.3, σ2 = 1, f00 = 0.9, f01 = f10 = 0.025, f11 =
0.05. The oracle Procedure 3.2, where the primary study is study one with σ1 = 0.3,
is also examined. For each procedure the estimated power and FDR is shown as a
function of the common expectation under the alternative, µ = µ1 = µ2. Procedure
4.1 with w1 = 1 is more powerful than with w1 = 0.5 or w1 = 0, while the choice
w1 = 0 is the worst in terms of power of Procedure 4.1. Moreover, Procedure 4.1
with w1 ∈ {0.5, 1} is more powerful than the BH procedure on maximum p-values.
These findings were consistent across all configurations of f00, f10, f01, f11 examined,
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when σ1 = 0.3 and σ2 = 1. Since the oracle Procedure 3.2 and the BH procedure on
maximum p-values do not depend on q1, their power curves are the same in figures
(a), (b), and (c). We see that Procedure 4.1 with w1 = 1 is a close second to the oracle
when q1 is 0.01 but is farther from the oracle as q1 increases. Similarly, the power of
Procedure 4.1 with w1 = 0.5 decreases as q1 increases. However, Procedure 4.1 with
w1 = 0 has largest power for q1 = 0.04, and the least power for q1 = 0.01. These
results are reasonable since the p-values of study one tend to be much smaller than
the p-values of study two when the no replicability null hypotheses are false. In Table
4 we see that if the p-value distribution of false no replicability null hypotheses is the
same across studies, then the optimal choice of q1 is q1 > q/2. For example, when
µ = µ1 = µ2 = 2 (row 2), the power is 0.65 with q1 = 0.005, 0.77 with q1 = 0.045,
and the maximum power is 0.81 with q1 = 0.035.
Table 4: The power of Procedure 3.2 with parameters (0.05c, 0.05) and the BH se-
lection rule at level 0.05c, for different values of µ = µ1 = µ2, with σ1 = σ2 = 0.5,
f00 = 0.9, f01 = f10 = 0.025, f11 = 0.05. The optimal value of c is in bold.
c = q1/0.05
µ 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9
1.5 0.143 0.195 0.224 0.245 0.257 0.258 0.248 0.226 0.181
2.0 0.646 0.718 0.755 0.778 0.794 0.803 0.805 0.800 0.769
2.5 0.934 0.955 0.965 0.971 0.975 0.977 0.978 0.978 0.974
Figure 2 compares the procedures (1) and (2) above for the same configuration of
fij , but for fixed µ = µ1 = µ2 and varying sample size of the two studies. The
varying power is described by the fraction ζ of sample allocated to the first study.
For the symmetric procedures, we see that for ζ = 0.1 the power is the lowest, and
it increases to reach its maximum for equal allocation ζ = 0.5. Procedure 4.1 with
w1 = 0.5 dominates the BH procedure on the maximum two study p-values. For
Procedure 4.1 with w1 = 1, the maximum is reached for ζ > 0.5. It is the most
powerful of the three procedures examined for ζ > 0.6.
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In Figure 3 we consider the FDR level of Procedure 4.1 with w1 ∈ {0, 0.5, 1}, as well
as of the naive procedure in the null setting, where all no replicability null hypotheses
are true (i.e. f11 = 0). The estimated FDR of (BH-i, BH-j) procedure exceeds 0.05 in
the settings where f10 = f01 = 0.5 and f00 = 0.8, f10 = f01 = 0.1. In these settings the
estimated FDR of both (BH-1, BH-2) and (BH-2, BH-1) procedures are increasing
functions of µ = µ1 = µ2, reaching one in the setting where f10 = f01 = 0.5 (left), and
0.4 in the setting where f00 = 0.8, f10 = f01 = 0.1 (right). Clearly, procedure (BH-i,
BH-j) is not valid since it may be far too liberal in terms of FDR level.
Finally, we examined how the selection rule affects the power. In Figure 4 we show the
power as a function of µ1 for Procedure 4.1 with parameters w1 = 0.5, q1 = 0.025, q =
0.05, for the following selection rules: BH at level 0.0125; the rule that selects the
hypotheses with k smallest primary study p-values, where k ∈ {25, 30, . . . , 100}. The
remaining parameters were: f00 = 0.9, f01 = f10 = 0.025, f11 = 0.05, σ1 = 0.5, σ2 =
1, µ2 = 3. For different values of µ1 the optimal k is different, and using the BH
procedure for selection is optimal for the entire range of µ1.
7 Discussion
In many research areas first a primary study is analyzed, then a follow-up study is
analyzed with the goal to corroborate the findings, or at least a subset of the findings,
of the primary study. We suggested novel testing procedures for corroborating the
evidence from a primary study in a follow-up study. We demonstrated their usefulness
on a GWAS application. In the setting where there is no division of roles to a primary
and a follow-up study, the simulations suggested that our novel Procedure 4.1 with
w1 = 0.5 is more powerful than the BH procedure on maximum p-values.
We proved that Procedures 3.2 and 4.1 control the FDR when the p-values are inde-
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(b) q1=0.025
0 0.5 1 1.5 2 2.5 3 3.5 4 4.5 5
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
mu
P
o
w
e
r
 
(c) q1=0.04
Figure 1: Power as a function of µ = µ1 = µ2, for q1 of (a) 0.01, (b) 0.025, and (c)
0.04, using the following procedures: the oracle Procedure 3.2 (solid with circles); the
BH procedure at level 0.05 applied on maximum p-values (dash-dotted); Procedure
4.1 at level 0.05 with w1 = 0 (dashed), w1 = 0.5 (dotted), and w1 = 1 (solid), where
the selection rule in steps 1 and 2 is the BH procedure at levels w1q1 and (1−w1)q1,
respectively. The remaining parameters were f00 = 0.9, f01 = 0.025, f10 = 0.025, f11 =
0.05, µ1 = µ2 = µ, σ1 = 0.3 and σ2 = 1.
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(b) µ = 3
Figure 2: Power as a function of fraction ζ of sample size allocated to the primary
study, for (a) µ1 = µ2 = 2, and (b) µ1 = µ2 = 3, for Procedure 4.1 with w1 = 1
(solid), with w1 = 0.5 (dotted), and for the BH procedure on the maximum of two
studies p-values (dash-dotted) at level q = 0.05. The remaining parameters were
f00 = 0.9, f01 = 0.025, f10 = 0.025, f11 = 0.05, sample size N = 1000, standard
deviation σ = 10.
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Figure 3: FDR versus µ = µ1 = µ2 for f01 = f10 = 0.5 (left) and f00 = 0.8, f01 =
f10 = 0.1 (right), for the following procedures at level q = 0.05: BH-1, BH-2 (solid
with circles); BH-2, BH-1 (dashed with circles); Procedure 4.1 with q1 = 0.025 and
w1 of 1 (solid), 0.5 (dotted), or 0 (dashed). The standard deviations were σ1 = 0.3
and σ2 = 1.
0 0.5 1 1.5 2 2.5 3 3.5
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
mu
Pow
er
Figure 4: Power as a function of µ1 for Procedure 4.1 with parameters w1 = 0.5, q1 =
0.025, q = 0.05 for the following selection rules: BH at level 0.0125 (solid black curve);
selection of the hypotheses with k smallest primary study p-values, where k = 25
(dashed green curve), k = 75 (dashed red curve), k ∈ {30, 35, . . . , 100} (dashed
grey curves). The remaining parameters were: f00 = 0.9, f01 = f10 = 0.025, f11 =
0.05, σ1 = 0.5, σ2 = 1, µ2 = 3.
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pendent within each study and the selection rule is valid. However, the assumption of
independence may not be realistic. Extensive simulations demonstrated that the BH
procedure controls the FDR for many types of dependence encountered in practice
(Yekutieli, 2008). We conjecture that this robustness property carries over to Proce-
dures 3.2 and 4.1, since Procedure 3.2 can be viewed as two-dimensional variant of
the BH procedure. For simulated GWAS examples the average false discovery pro-
portion was below the nominal FDR level, suggesting that the procedures are indeed
valid for the type of dependency that occurs in GWAS. More conservative variants
of Procedure 3.2 were given in Theorem 3.3 and in Section 3 of the Supplementary
Material, that guarantee that the FDR is controlled for arbitrary dependence among
the primary study p-values, and dependence of type PRDS or arbitrary dependence
among the follow-up study p-values. We demonstrated the usefulness of the variants
suggested in Theorem 3.3 in Example 2 of Section 5. Out of the 36 replicability dis-
coveries with Procedure 3.2, 23 discoveries passed the more stringent requirement that
came with the added guarantee that the FDR is controlled for arbitrary dependence
among the 635,547 p-values in the primary study.
Replicability analysis, as suggested in this paper, requires that the investigators make
several key design choices in addition to the error level q: the selection rule, q1, and
w1 if two studies are available without division into primary and follow-up. The
power of the procedure for replicability analysis varies with these choices. From our
investigations, it appears reasonable in Procedure 3.2 to select hypotheses by BH at
level q1, and to set w1 = 0.5 in Procedure 4.1 if the p-value distributions for false null
hypotheses may be assumed to be similar in both studies. We gave some guidelines
for choosing q1 in specific settings, and more general guidelines are a topic for future
research.
In replicability analysis, the primary study guides the design of the follow-up study
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by supplying the subset of hypotheses to be followed-up. Since the primary study also
yields information on effect sizes, if it is assumed that the effect sizes are the same
across studies, then this information may be used in order to determine the sample
size needed to obtain good power in the follow-up study. However, this assumption
may be unrealistic in applications such as GWAS, where the LD pattern varies across
populations.
Finally, we saw that although Procedure 4.1 with parameters (w1, q1, q) is far less
conservative than the BH procedure at level q on maximum p-values, it is still con-
servative. We proved that Procedure 4.1 with less conservative parameters q′1 > q1
and q′ > q, still controls the FDR at level q on the family of no replicability null hy-
potheses, if |I00| and |I01| were known. In future research we will consider estimates
of these unknown parameters.
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A Proof of Theorem 3.2
Let q2 = q − q1, and for each j ∈ {1, . . . , m}, let P (j)1 and P (j)2 denote the vectors
P1 = (P11, . . . , P1m) and P2 = (P21, . . . , P2m) with, respectively, P1j and P2j excluded.
For j ∈ {1, . . . , m} arbitrary fixed, let R(j)1 (P (j)1 ) ⊆ {1, . . . , j − 1, j + 1, . . . , m} be
the subset of indices selected along with index j. Note that since the selection rule
is valid, this subset is well defined. For any j ∈ {1, . . . , m} and given P (j)1 , for
i ∈ 1, . . . , j − 1, j + 1, . . . , m we define
Ti =

max
(
mP1i
q1
,
(|R
(j)
1 (P
(j)
1 )|+1)P2i
q2
)
if i ∈ R(j)1 (P (j)1 ),
∞ otherwise.
Let T(1) ≤ . . . ≤ T(m−1) be the sorted T -values, and T(0) = 0. For r = 1, . . . , m, we
define C
(j)
r as the event in which if HNR,j is rejected by Procedure 3.2, r hypotheses
are rejected including HNR,j :
C(j)r = {(P (j)1 , P (j)2 ) : T(r−1) ≤ r, T(r) > r + 1, T(r+1) > r + 2, . . . , T(m−1) > m}.
Note that given P1, for r > |R1|, C(j)r = ∅, since exactly |R1| − 1 Ti’s are finite.
Obviously, C
(j)
r and C
(j)
r′ are disjoint events for any r 6= r′, and ∪mr=1C(j)r is the
entire space of (P
(j)
1 , P
(j)
2 ). Let I0 = I01 ∪ I00, Rj be the indicator of whether HNR,j
was rejected for j = 1, . . . , m, and R =
∑m
j=1Rj. The FDR for the family of no
replicability null hypotheses is
FDR = E
( ∑
j∈I0
Rj
max(R, 1)
)
+ E
(∑
j∈I10
Rj
max(R, 1)
)
(A.1)
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First, we find an upper bound for the first term of the sum in (A.1).
E
( ∑
j∈I0
Rj
max(R, 1)
)
=
∑
j∈I0
m∑
r=1
1
r
Pr
(
j ∈ R1, P1j ≤ rq1
m
,P2j ≤ r(q − q1)|R1| , C
(j)
r
)
≤
∑
j∈I0
m∑
r=1
1
r
Pr
(
P1j ≤ rq1
m
,C(j)r
)
=
∑
j∈I0
m∑
r=1
1
r
Pr
(
P1j ≤ rq1
m
)
Pr
(
C(j)r
)
(A.2)
≤ q1
m
∑
j∈I0
m∑
r=1
Pr
(
C(j)r
)
=
|I0|
m
q1 (A.3)
The equality in (A.2) follows from the independence of the p-values. The inequality
in (A.3) follows from the fact that for each j ∈ I0, Pr(P1j ≤ x) ≤ x for all x ∈ [0, 1].
Finally, the equality in (A.3) follows from the fact that ∪mr=1C(j)r is the entire sample
space of (P
(j)
1 , P
(j)
2 ), represented as a union of disjoint events.
Next, we find an upper bound for the second term of the sum in (A.1). Let R1(p1)
be the set of selected indices using P1 = p1. Then E
(∑
j∈I10
Rj/max(R, 1) |P1 = p1
)
equals to:
∑
j∈I10∩R1(p1)
|R1(p1)|∑
r=1
1
r
I
[
p1j ≤ rq1
m
]
Pr
(
P2j ≤ rq2|R1(p1)| , C
(j)
r |P1 = p1
)
≤
∑
j∈I10∩R1(p1)
|R1(p1)|∑
r=1
1
r
Pr
(
P2j ≤ rq2|R1(p1)| , C
(j)
r |P1 = p1
)
(A.4)
=
∑
j∈I10∩R1(p1)
|R1(p1)|∑
r=1
1
r
Pr
(
P2j ≤ rq2|R1(p1)| |P1 = p1
)
Pr
(
C(j)r |P1 = p1
)
(A.5)
≤ q2|R1(p1)|
∑
j∈I10∩R1(p1)
|R1(p1)|∑
r=1
Pr
(
C(j)r |P1 = p1
)
=
q2
|R1(p1)| |I10 ∩ R1(p1)|. (A.6)
The equality in (A.5) follows from the fact that P2j , P
(j)
2 , P1 are independent, since
then C
(j)
r and the event {P2j ≤ rq2/|R1(p1)|} are conditionally independent. The
inequality in (A.6) follows from the independence of the p-values across the studies
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and the fact that for each j ∈ I10, Pr(P2j ≤ x) ≤ x for all x ∈ [0, 1]. The equality
in (A.6) follows from the fact that ∪|R1(p1)|r=1 C(j)r is a union of disjoint events, and
Pr
(
∪|R1(p1)|r=1 C(j)r |P1 = p1
)
= 1.
It follows from (A.6) that E
(∑
j∈I10
Rj/max(R, 1)
)
≤ q2. Using this fact and the
bound (A.3) for the first term of (A.1), we obtain:
FDR ≤ |I0|
m
q1 + (q − q1) ≤ q1 + (q − q1) = q.
B Proof for FDR control of the oracle Procedure
3.2
Let us now prove that under the assumption that the p-values are independent, Pro-
cedure 3.2 at levels (q′, 2q′) controls the FDR at level |I00| (q′)2 /m+ (|I01|/m+ 1) q′.
Returning to the proof of Theorem 3.2, note that (A.1) can be rewritten as follows.
FDR = E
(∑
j∈I00
Rj
max(R, 1)
)
+ E
(∑
j∈I01
Rj
max(R, 1)
)
+ E
(∑
j∈I10
Rj
max(R, 1)
)
. (B.1)
We will now give an upper bound for each term of the sum in (B.1). First,
E
(∑
j∈I00
Rj
max(R, 1)
)
=
∑
j∈I00
m∑
r=1
1
r
Pr
(
j ∈ R1, P1j ≤ rq
′
m
,P2j ≤ rq
′
|R1| , C
(j)
r
)
≤
∑
j∈I00
m∑
r=1
1
r
Pr
(
P1j ≤ rq
′
m
,P2j ≤ q′, C(j)r
)
≤ (q
′)2
m
∑
j∈I00
m∑
r=1
Pr
(
C(j)r
)
=
|I00|
m
(q′)2
(B.2)
The second inequality in (B.2) follows from the facts that for each j ∈ I00, P1j and
P2j are independent, and Pr(Pij ≤ x) ≤ x for all x ∈ [0, 1] and i = 1, 2. The equality
in (B.2) follows from the explanation of the equality in (A.3).
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Second, replacing I0 by I01 and |I0| by |I01| in the arguments that led to (A.3), we
obtain:
E
(∑
j∈I01
Rj
max(R, 1)
)
≤ |I01|
m
q′. (B.3)
Finally, using (A.6) in the proof of Theorem 3.2 we obtain that the third term of the
sum in (B.1) is bounded by q2 = 2q
′− q′ = q′. Using this upper bound, together with
the bounds for the first two terms derived in (B.2) and (B.3), we obtain:
FDR ≤ |I00|
m
(q′)2 +
|I01|
m
q′ + q′ =
|I00|
m
(q′)2 +
( |I01|
m
+ 1
)
q′.
It follows that if |I00| and |I01| were known, one could guarantee FDR control at level
q on the family of no replicability null hypotheses by applying Procedure 3.2 at levels
(q′, 2q′), where q′ is the solution to |I00| (q′)2 /m+ (|I01|/m+ 1) q′ = q.
C Proof of Theorem 4.1
Let V12 =
∑
j∈I00∪I01∪I10
I [j ∈ R12,w1q] and R12 = |R12,w1q| denote the number of
erroneously rejected and the total number of rejected no replicability null hypothe-
ses by Procedure 3.2 at level w1q with study one as the primary study and study
two as the follow-up study. Similarly, let V21 =
∑
j∈I00∪I01∪I10
I
[
j ∈ R21,(1−w1)q
]
and
R21 = |R21,(1−w1)q| denote the number of erroneously rejected and the total num-
ber of rejected no replicability null hypotheses by Procedure 3.2 at level (1 − w1)q
with study two as the primary study and study one as the follow-up study. Define
Rs = R12,w1q ∪R21,(1−w1)q, the indices of the no replicability null hypotheses rejected
by Procedure 4.1. Let Vs =
∑
j∈I00∪I01∪I10
I [j ∈ Rs] and Rs = |Rs|, the number of
erroneously rejected and the total number of rejected no replicability null hypotheses
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by Procedure 4.1.
Note that Vs ≤ V12 + V21. Therefore,
FDR = E
(
Vs
max(Rs, 1)
)
≤ E
(
V12
max(Rs, 1)
)
+ E
(
V21
max(Rs, 1)
)
. (C.1)
In addition, note that max(Rs, 1) ≥ max(R12, 1) and max(Rs, 1) ≥ max(R21, 1).Using
these facts and (C.1) we obtain
FDR = E
(
Vs
max(Rs, 1)
)
≤ E
(
V12
max(R12, 1)
)
+ E
(
V21
max(R21, 1)
)
≤ w1q + (1− w1)q = q,
where the last inequality follows from Theorem 3.2.
D Table of results for GWAS of Crohn’s disease
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Table 5: Replicability analysis for Example 2 in Section 5: GWAS of Crohns disease.
The number of SNPs in the primary study was 635,547, and 126 SNPs were followed-
up. The 36 discoveries by Procedure 3.2 with parameters (q1, q) = (0.04, 0.05) are
listed according to the adjusted p-values. The primary and follow-up studies p-values
are given in columns 4 and 5; the adjusted p-values for c = 0.8 are given in column 6
for Procedure 3.2, and in column 7 for the modification of item 1 in Theorem 3.3.
Index Chromosome Position p1 p2 p
REPadj
FDR p˜
REPadj
FDR
1 1 67417979 3.19e-34 1.5e-36 2.53e-28 3.53e-27
2 1 67414547 5.05e-36 3.1e-29 9.69e-27 9.69e-27
3 1 67387537 1.35e-24 5.62e-17 1.17e-14 1.17e-14
4 2 233962410 5.66e-21 7.67e-14 1.2e-11 1.2e-11
5 10 64108492 9.51e-12 1.61e-10 1.51e-06 1.5e-05
6 5 40428485 2.51e-22 2.79e-08 2.84e-06 3.31e-06
7 5 40437266 2.26e-22 3.18e-08 2.84e-06 3.31e-06
8 10 101281583 8.53e-11 1.69e-07 1.32e-05 7.74e-05
9 18 12769947 5.95e-12 2.41e-07 1.61e-05 1.88e-05
10 5 150239060 3.18e-11 2.57e-07 1.61e-05 3.91e-05
11 10 101282445 9.09e-11 3.1e-07 1.76e-05 7.74e-05
12 5 150203580 4.09e-11 7.47e-07 3.89e-05 4.67e-05
13 18 12799340 3.27e-11 1.23e-06 5.91e-05 6.99e-05
14 5 131798704 2.29e-09 3.52e-11 0.00013 0.00169
15 5 158747111 4.4e-09 3.66e-06 0.000233 0.00305
16 2 233965368 1.28e-21 3.66e-05 0.00143 0.00163
17 13 43355925 8.04e-08 1.33e-07 0.00376 0.0469
18 12 39104262 8.95e-08 6.55e-05 0.00395 0.0496
19 3 49676987 9.47e-08 2.24e-06 0.00396 0.0499
20 3 49696536 1.08e-07 5.64e-07 0.00429 0.0544
21 12 38888207 6.64e-08 0.000165 0.00491 0.0433
22 6 167408399 1.65e-07 3.26e-07 0.00596 0.0731
23 9 114645994 1.96e-07 6.58e-05 0.00677 0.0768
24 6 20836710 1.26e-07 0.000278 0.00724 0.0607
25 1 169593891 2.01e-07 0.000321 0.00802 0.0768
26 1 197667523 3.41e-07 2.34e-06 0.01 0.111
27 9 4971602 3.4e-07 0.00043 0.01 0.111
28 1 157665119 1.75e-07 0.000481 0.0107 0.0745
29 11 75978964 7.16e-08 0.000732 0.0158 0.044
30 20 61798026 7.6e-07 0.000138 0.0201 0.234
31 6 167405736 1.65e-07 0.00121 0.0241 0.0731
32 1 197691964 9.69e-07 1e-04 0.0241 0.29
33 17 35294289 1.06e-06 0.000292 0.0255 0.308
34 8 126603853 1.9e-06 0.000182 0.0431 0.457
35 6 106541962 1.85e-06 7.7e-06 0.0431 0.457
36 9 4978761 1.96e-06 0.00162 0.0433 0.462
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E A computational example with FWER control
When the FWER controlling procedure applied in each stage of Procedure 3.1 is
Bonferroni, then HNR,j is rejected if p1j ≤ α1/m and p2j ≤ (α − α1)/
∑m
i=1 I[p1j ≤
α1/m], where I[·] is the indicator function. An alternative to Procedure 3.1 is to apply
a FWER controlling procedure, such as Bonferroni, on the maximum of p-values from
the two studies. This alternative procedure also controls the FWER on the family
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of no replicability null hypotheses. In the alternative procedure, Hj is rejected if
p1j ≤ α/m and p2j ≤ α/m. The two procedures differ in the thresholds used in each
of the studies. The cut-off for p1j is larger in the alternative procedure, since α1 < α.
However, the cut-off for p2j may be substantially smaller in the alternative procedure,
since (α−α1)/
∑m
i=1 I[p1j ≤ α1/m] may be significantly larger than α/m. This is so in
the common setting where signal is sparse in the primary study, i.e.
∑m
j=1 h1j ≪ m.
Example E.1. Suppose we have m independent normal outcomes in each of the two
studies T1j , T2j, j = 1 . . . , m . In this example, E(T11) = µ11, E(T21) = µ21, V ar(T11) =
V ar(T21) = 1, and outcomes j = 2, . . . , m have expectation 0 and variance 1. Con-
sider first the power of the alternative procedure that applies Bonferroni on the max-
imum of the two study p-values for FWER control at level α = 0.05:
pi1 =
∼
Φ (z1−α/m − µ11)×
∼
Φ (z1−α/m − µ21),
where
∼
Φ (·) is the right tail of the standard normal distribution. Next, we compute
the power of Procedure 3.1 with Bonferroni as the FWER controlling procedure. The
probability of correctly selecting (PCS) the non-null hypothesis in the first study as
well as k − 1 null hypotheses along with it is
PCS(k) =
∼
Φ (z1−α1/m − µ11)
(
m− 1
k − 1
)
(α1/m)
k−1(1− α1/m)m−k,
so the power is
pi2 =
m∑
k=1
PCS(k)× ∼Φ (z1−(α−α1)/k − µ21).
Figure 5 shows the power of the Bonferroni on maximum p-values procedure (left
panel) and the power of Procedure 3.1 (right panel) for different configurations of
(µ11, µ21), where (α1, α) = (0.025, 0.05). In most configurations of µ11 and µ21,
Procedure 3.1 is more powerful than the Bonferroni on maximum p-values proce-
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Figure 5: The power as function of the expectation in the first study (x-axis) and the
expectation in the second study (y-axis), for the false no replicability null hypothesis,
in a setting where one no replicability null hypothesis is false out of 100 no replicability
null hypotheses. Left panel: Procedure that applies a Bonferroni correction on the
maximum two study p-values for FWER control at level 0.05. Right panel: Procedure
3.1 with (α1, α) = (0.025, 0.05) and Bonferroni as the FWER controlling procedure.
dure. Moreover, for fixed µ1 > µ2, the power of the two stage procedure is larger if
(µ11, µ21) = (µ1, µ2) than if (µ11, µ21) = (µ2, µ1).
Figure 6 shows the difference in power of Procedure 3.1 using Bonferroni with c =
α1/α ∈ {0.2, 0.5, 0.8}, as well as the Bonferroni procedure on maximum p-values,
from the power of Procedure 3.1 with optimal choice of c. Clearly, Procedure 3.1
with optimal choice of c can be much more powerful than the Bonferroni procedure
on maximum p-values. Moreover, for the three choices c = 0.2, c = 0.5 and c = 0.8,
the difference in power from the optimal power is fairly small, especially when the
optimal power is above 0.9 (right panel). Figure 7 shows the power as a function of c
for three configurations of (µ11, µ21), for which the power using the optimal c is 0.9.
The power function is quite flat. The optimal c is below 0.5 in the top left panel, and
above 0.5 in the top right and bottom panel. However, the difference in power between
Procedure 3.1 with c = 0.5 and Procedure 3.1 with optimal c is small.
37
c=0.2 c=0.5 c=0.8 Bonf. on max
−
0.
6
−
0.
5
−
0.
4
−
0.
3
−
0.
2
−
0.
1
0.
0
Po
w
e
r 
di
ffe
re
n
ce
c=0.2 c=0.5 c=0.8 Bonf. on max
−
0.
5
−
0.
4
−
0.
3
−
0.
2
−
0.
1
0.
0
Po
w
e
r 
di
ffe
re
n
ce
Figure 6: The difference in power of Procedure 3.1 using Bonferroni with c = α1/α ∈
{0.2, 0.5, 0.8}, as well as the Bonferroni procedure on maximum p-values, from the
power of Procedure 3.1 with optimal c. Left panel: for all pairs of configurations
where µ11 ∈ {0, 0.5, 1.0, . . . , 10} and µ21 ∈ {0, 0.5, 1.0, . . . , 10}. Right panel: Subset
of configurations of (µ11, µ21) for which the power with optimal choice c is above 0.90.
F Proof of Theorem 3.3
We use the notation given in the first two paragraphs of Appendix A of the main
manuscript, including: q2 = q− q1; Rj is the indicator of whether HNR,j was rejected
for j = 1, . . . , m, and R =
∑m
j=1Rj . In addition we define: I0 = I00 ∪ I01; p1 =
(p11, . . . , p1m); R1(p1) is the set of hypotheses selected for follow-up based on p1,
R1(p1) = |R1(p1)|.
Lemma F.1. Assume that the p-values across studies are independent, and the set of
p-values within the follow-up study has property PRDS. Then for any valid selection
rule, the following results hold:
1. Given p1, for j ∈ I10 ∩ R1(p1),
R1(p1)∑
r=1
Pr
(
C(j)r |P2j ≤
rq2
R1(p1)
, P1 = p1
)
≤ 1.
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Figure 7: The power of Procedure 3.1 using Bonferroni as function of c = α1/α for
the false no replicability null hypothesis, for the following configurations of (µ11, µ21):
(5.5, 3.0) in the top left panel; (4.5, 4.5) in the top right panel; (4.5, 5.0) in the
bottom panel. The power of the Bonferroni procedure on maximum p-values is the
dotted horizontal line.
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2. For Procedure 3.2 with parameters (q1, q),
E
(∑
j∈I10
Rj
max(R, 1)
)
≤ q2.
3. Item 2 holds if in the terms rq1/m and R2q1/m in step 2 of Procedure 3.2, q1
is replaced by q′1, for any value of q
′
1.
See Section F.1 for a proof.
Proof of item 1 of Theorem 3.3. We will first show that the first term of
the sum in (A.1) is bounded by |I0| q1/m. We will use the technique developed in
Benjamini and Yekutieli (2001) in the proof of their Theorem 1.3. For each j ∈
I0, r ∈ {1, . . . , m}, and l ∈ {1, . . . , m}, let us define:
pjrl = Pr
(
P1j ∈
(
(l − 1)q1
m
∑m
s=1
1
s
,
lq1
m
∑m
s=1
1
s
]
, C(j)r
)
.
Since ∪mr=1C(j)r is the entire sample space represented as a union of disjoint events, we
obtain for each j ∈ I0 and l ∈ {1, . . . , m}:
m∑
r=1
pjrl = Pr
(
P1j ∈
(
(l − 1)q1
m
∑m
s=1
1
s
,
lq1
m
∑m
s=1
1
s
]
, ∪mr=1C(j)r
)
= Pr
(
P1j ∈
(
(l − 1)q1
m
∑m
s=1
1
s
,
lq1
m
∑m
s=1
1
s
])
. (F.1)
Note that for j ∈ I0, Pr (P1j ≤ x) ≤ x for all x ≥ 0, in particular Pr (P1j = 0) = 0.
Therefore, for each j ∈ I0 and r ∈ {1, . . . , m},
Pr
(
P1j ≤ rq1
m
∑m
s=1
1
s
, C(j)r
)
=
r∑
l=1
pjrl. (F.2)
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The upper bound on the first term of the sum in (A.1) is derived as follows.
E
( ∑
j∈I0
Rj
max(R, 1)
)
=
∑
j∈I0
m∑
r=1
1
r
Pr
(
j ∈ R1, P1j ≤ rq1
m
∑m
s=1
1
s
, P2j ≤ r(q − q1)|R1| , C
(j)
r
)
≤
∑
j∈I0
m∑
r=1
1
r
Pr
(
P1j ≤ rq1
m
∑m
s=1
1
s
, C(j)r
)
(F.3)
=
∑
j∈I0
m∑
r=1
r∑
l=1
1
r
pjrl =
∑
j∈I0
m∑
l=1
m∑
r=l
1
r
pjrl (F.4)
≤
∑
j∈I0
m∑
l=1
m∑
r=l
1
l
pjrl ≤
∑
j∈I0
m∑
l=1
1
l
m∑
r=1
pjrl
=
∑
j∈I0
m∑
l=1
1
l
Pr
(
P1j ∈
(
(l − 1)q1
m
∑m
s=1
1
s
,
lq1
m
∑m
s=1
1
s
])
, (F.5)
where the first equality in (F.4) follows from (F.2), and the equality in (F.5) follows
from (F.1). Note that for each j ∈ I0,
m∑
l=1
1
l
Pr
(
P1j ∈
(
(l − 1)q1
m
∑m
s=1
1
s
,
lq1
m
∑m
s=1
1
s
])
=
m∑
l=1
1
l
[
Pr
(
P1j ≤ lq1
m
∑m
s=1 1/s
)
− Pr
(
P1j ≤ (l − 1)q1
m
∑m
s=1 1/s
)]
=
m∑
l=1
1
l
Pr
(
P1j ≤ lq1
m
∑m
s=1 1/s
)
−
m−1∑
l=0
1
l + 1
Pr
(
P1j ≤ lq1
m
∑m
s=1 1/s
)
=
m−1∑
l=1
(
1
l
− 1
l + 1
)
Pr
(
P1j ≤ lq1
m
∑m
s=1 1/s
)
+
1
m
Pr
(
P1j ≤ q1∑m
s=1 1/s
)
≤
m−1∑
l=1
1
l + 1
(
q1
m
∑m
s=1 1/s
)
+
q1
m
∑m
s=1 1/s
(F.6)
=
(
q1
m
∑m
s=1 1/s
) m∑
l=1
1
l
=
q1
m
. (F.7)
The inequality in (F.6) follows from the fact that for j ∈ I0, Pr(P1j ≤ x) ≤ x for all
x ≥ 0. Combining (F.7) with (F.5) we obtain an upper bound for the first term of
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the sum in (A.1):
E
( ∑
j∈I0
Rj
max(R, 1)
)
≤
∑
j∈I0
q1
m
=
|I0| q1
m
. (F.8)
It follows from Lemma F.1, item 3, that the second term of the sum in (A.1) is
bounded by q2, hence
FDR ≤ |I0| q1
m
+ q2 =
|I0| q1
m
+ q − q1 ≤ q.
Proof of item 2 of Theorem 3.3. We will first prove that the first term of the
sum in (A.1) is bounded by q1. For q˜1 as defined in item 2 of Theorem 3.3, we denote
k = ⌈tm/q˜1 − 1⌉ . The first term of the sum in (A.1) is upper bounded by two terms:
E
( ∑
j∈I0
Rj
max(R, 1)
)
=
∑
j∈I0
m∑
r=1
1
r
Pr
(
j ∈ R1, P1j ≤ rq˜1
m
,P2j ≤ r(q − q1)|R1| , C
(j)
r
)
≤
∑
j∈I0
m∑
r=1
1
r
Pr
(
P1j ≤ min
(
rq˜1
m
, t
)
, C(j)r
)
(F.9)
=
∑
j∈I0
k∑
r=1
1
r
Pr
(
P1j ≤ rq˜1
m
, C(j)r
)
+
∑
j∈I0
m∑
r=k+1
1
r
Pr
(
P1j ≤ t, C(j)r
)
,
(F.10)
where the inequality in (F.9) follows from the fact that j ∈ R1 yields that P1j ≤ t.
We will now find an upper bound for each of the two terms in (F.10) separately. The
derivation of the upper bound for the first term is along the lines of the derivation in
the proof of item 1. We give it below for completeness.
For each j ∈ I0, r ∈ {1, . . . , m}, and l ∈ {1, . . . , m}, let us define:
p˜jrl = Pr
(
P1j ∈
(
(l − 1)q˜1
m
,
lq˜1
m
]
, C(j)r
)
. (F.11)
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As in expression (F.2), for each j ∈ I0 and r ∈ {1, . . . , k} one has:
Pr
(
P1j ≤ rq˜1
m
, C(j)r
)
=
r∑
l=1
p˜jrl.
Using this equality we obtain:
∑
j∈I0
k∑
r=1
1
r
Pr
(
P1j ≤ rq˜1
m
, C(j)r
)
=
∑
j∈I0
k∑
r=1
r∑
l=1
1
r
p˜jrl =
∑
j∈I0
k∑
l=1
k∑
r=l
1
r
p˜jrl
≤
∑
j∈I0
k∑
l=1
k∑
r=l
1
l
p˜jrl ≤
∑
j∈I0
k∑
l=1
1
l
k∑
r=1
p˜jrl. (F.12)
Since ∪kr=1C(j)r is a union of disjoint events, we obtain for each j ∈ I0 and l ∈
{1, . . . , k}:
k∑
r=1
p˜jrl = Pr
(
P1j ∈
(
(l − 1)q˜1
m
,
lq˜1
m
]
, ∪kr=1C(j)r
)
≤ Pr
(
P1j ∈
(
(l − 1)q˜1
m
,
lq˜1
m
])
= Pr
(
P1j ≤ lq˜1
m
)
− Pr
(
P1j ≤ (l − 1)q˜1
m
)
.
Therefore for each j ∈ I0 we obtain:
k∑
l=1
1
l
k∑
r=1
p˜jrl ≤
k∑
l=1
1
l
[
Pr
(
P1j ≤ lq˜1
m
)
− Pr
(
P1j ≤ (l − 1)q˜1
m
)]
=
k∑
l=1
1
l
Pr
(
P1j ≤ lq˜1
m
)
−
k−1∑
l=0
1
l + 1
Pr
(
P1j ≤ lq˜1
m
)
=
k−1∑
l=1
(
1
l
− 1
l + 1
)
Pr
(
P1j ≤ lq˜1
m
)
+
1
k
Pr
(
P1j ≤ kq˜1
m
)
≤
k−1∑
l=1
1
l + 1
(
q˜1
m
)
+
q˜1
m
=
(
q˜1
m
) k∑
l=1
1
l
. (F.13)
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The inequality in (F.13) follows from the fact that for j ∈ I0, Pr(P1j ≤ x) ≤ x for all
x ≥ 0. Combining (F.13) with (F.12) we obtain an upper bound for the first term of
the sum in (F.10):
∑
j∈I0
k∑
r=1
1
r
Pr
(
P1j ≤ rq˜1
m
, C(j)r
)
≤
∑
j∈I0
(
q˜1
m
) k∑
l=1
1
l
=
|I0| q˜1
m
k∑
l=1
1
l
. (F.14)
We will now find an upper bound for the second term of the sum in (F.10):
∑
j∈I0
m∑
r=k+1
1
r
Pr
(
P1j ≤ t, C(j)r
)
=
∑
j∈I0
m∑
r=k+1
1
r
Pr (P1j ≤ t) Pr
(
C(j)r |P1j ≤ t
)
≤
∑
j∈I0
m∑
r=k+1
t
r
Pr
(
C(j)r |P1j ≤ t
)
(F.15)
≤ q˜1
m
∑
j∈I0
m∑
r=k+1
Pr
(
C(j)r |P1j ≤ t
)
(F.16)
=
q˜1
m
∑
j∈I0
Pr
(∪mr=k+1C(j)r |P1j ≤ t) ≤ |I0| q˜1m . (F.17)
The inequality in (F.15) follows from the fact that for j ∈ I0, Pr(P1j ≤ x) ≤ x for all
x ≥ 0. The inequality in (F.16) follows from the fact that for all r ≥ k + 1, it holds
that r ≥ ⌈tm/q˜1− 1⌉+1 = ⌈tm/q˜1⌉ ≥ tm/q˜1, yielding that t/r ≤ q˜1/m. The equality
in (F.17) follows from the fact that ∪mr=k+1C(j)r is a union of disjoint events.
Combining (F.10), (F.14) and (F.17) we obtain an upper bound for the first term of
the sum in (A.1):
E
( ∑
j∈I0
Rj
max(R, 1)
)
≤ |I0| q˜1
m
k∑
l=1
1
l
+
|I0| q˜1
m
≤ q˜1
(
1 +
k∑
l=1
1
l
)
= q1. (F.18)
Note that for t ≤ q1/m, ⌈tm/q1−1⌉ = 0, therefore q1 = max{x : x(1+
∑⌈mt/x−1⌉
i=1 1/i) =
q1}. We obtain q˜1 = q1, which yields that in this case no modification is required.
It follows from Lemma F.1, item 3, that the second term of the sum in (A.1) is
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bounded by q2. Combining this result with (F.18), we obtain
FDR ≤ q1 + q2 = q1 + q − q1 = q.
F.1 Proof of Lemma F.1
Proof of item 1. Our proof is similar to the proof of Theorem 1.2 in Benjamini and Yekutieli
(2001). For j ∈ {1, . . . , m} and s ∈ {1, . . . , m−1} we define the event D(j)s as follows:
D(j)s = {(P (j)1 , P (j)2 ) : T(s) > s+ 1, T(s+1) > s+ 2, . . . , T(m−1) > m},
and we define D
(j)
m to be the entire sample space of (P
(j)
1 , P
(j)
2 ). Note that D
(j)
s =
∪sr=1C(j)r . It is easy to see that D(j)s is the event in which if HNR,j is rejected by
Procedure 3.2, at most s hypotheses are rejected including HNR,j.
We will first show that for each p1, j ∈ I10∩R1(p1) and s ∈ {1, . . . , m−1}, D(j)s ∩{P1 =
p1} is an increasing set for P (j)2 , i.e. if (P1, P (j)2 ) ∈ D(j)s ∩ {P1 = p1} and P˜ (j)2 ≥ P (j)2 ,
then (P1, P˜
(j)
2 ) ∈ D(j)s ∩ {P1 = p1}. The result follows from the fact that for fixed
P1 = p1 and j ∈ I10 ∩R1(p1), Ti =∞ for i /∈ R(j)1 (p(j)1 ), and Ti is increasing in P2i for
i ∈ R(j)1 (p(j)1 ).
For a given p1 and j ∈ I10 ∩ R1(p1), using the fact that for each s ∈ {1, . . . , m− 1},
D
(j)
s ∩ {P1 = p1} is an increasing set for P (j)2 , as well as the PRDS property of the
p-values from the follow-up study and the independence of the p-values across the
studies, we obtain for each s ∈ {1, . . . , R1(p1)− 1}:
Pr
(
D(j)s |P2j ≤
sq2
R1(p1)
, P1 = p1
)
≤ Pr
(
D(j)s |P2j ≤
(s+ 1)q2
R1(p1)
, P1 = p1
)
. (F.19)
Using the fact that for each s ∈ {1, . . . , R1(p1)− 1}, D(j)s ∪ C(j)s+1 = D(j)s+1, where D(j)s
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and C
(j)
s+1 are disjoint events, and the fact that D
(j)
1 = C
(j)
1 we obtain:
R1(p1)∑
r=1
Pr
(
C(j)r |P2j ≤
rq2
R1(p1)
, P1 = p1
)
=
Pr
(
D
(j)
1 |P2j ≤
q2
R1(p1)
, P1 = p1
)
+
R1(p1)∑
r=2
[
Pr
(
D(j)r |P2j ≤
rq2
R1(p1)
, P1 = p1
)
− Pr
(
D
(j)
r−1 |P2j ≤
rq2
R1(p1)
, P1 = p1
)]
=
R1(p1)∑
r=1
Pr
(
D(j)r |P2j ≤
rq2
R1(p1)
, P1 = p1
)
−
R1(p1)−1∑
r=1
Pr
(
D(j)r |P2j ≤
(r + 1)q2
R1(p1)
, P1 = p1
)
≤
R1(p1)∑
r=1
Pr
(
D(j)r |P2j ≤
rq2
R1(p1)
, P1 = p1
)
−
R1(p1)−1∑
r=1
Pr
(
D(j)r |P2j ≤
rq2
R1(p1)
, P1 = p1
)
(F.20)
= Pr
(
D
(j)
R1(p1)
|P2j ≤ q2, P1 = p1
)
= 1,
where the inequality in (F.20) follows from (F.19).
Proof of item 2. Let p1 be arbitrary fixed. Then,
E
(∑
j∈I10
Rj/max(R, 1) |P1 = p1
)
=
∑
j∈I10∩R1(p1)
R1(p1)∑
r=1
1
r
I
[
p1j ≤ rq1
m
]
Pr
(
P2j ≤ rq2
R1(p1)
, C(j)r |P1 = p1
)
≤
∑
j∈I10∩R1(p1)
R1(p1)∑
r=1
1
r
Pr
(
P2j ≤ rq2
R1(p1)
, C(j)r |P1 = p1
)
(F.21)
=
∑
j∈I10∩R1(p1)
R1(p1)∑
r=1
1
r
Pr
(
P2j ≤ rq2
R1(p1)
|P1 = p1
)
Pr
(
C(j)r |P2j ≤
rq2
R1(p1)
, P1 = p1
)
≤ q2
R1(p1)
∑
j∈I10∩R1(p1)
R1(p1)∑
r=1
Pr
(
C(j)r |P2j ≤
rq2
R1(p1)
, P1 = p1
)
≤ q2
R1(p1)
|I10 ∩R1(p1)|.
(F.22)
46
The first inequality in (F.22) follows from the independence of the p-values across the
studies and the fact that for each j ∈ I10, Pr(P2j ≤ x) ≤ x for all x ≥ 0. The second
inequality in (F.22) follows from Lemma F.1, item 1. Taking the expectation over P1,
we obtain E
(∑
j∈I01
Rj/max(R, 1)
)
≤ q2.
Proof of item 3. For q′1 and p1 arbitrary fixed,
E
(∑
j∈I10
Rj/max(R, 1) |P1 = p1
)
=
∑
j∈I10∩R1(p1)
R1(p1)∑
r=1
1
r
I
[
p1j ≤ rq
′
1
m
]
Pr
(
P2j ≤ rq2
R1(p1)
, C(j)r |P1 = p1
)
≤
∑
j∈I10∩R1(p1)
R1(p1)∑
r=1
1
r
Pr
(
P2j ≤ rq2
R1(p1)
, C(j)r |P1 = p1
)
.
The arguments that lead from (F.21) to the result of item 2 complete the proof.
G Additional theoretical results under dependence
Theorem G.1. Assume that the p-values across studies are independent, the p-values
within the primary study are independent, and the set of p-values within the follow-up
study has property PRDS. If the selection rule used in step 1 of Procedure 3.2 is a
valid selection rule, then Procedure 3.2 with parameters (q1, q) controls the FDR at
level q for the family of no replicability null hypotheses HNR,1, . . . , HNR,m.
Proof. Let us first find an upper bound for the first term of the sum in (A.1). Note
that (A.3) is established using the independence of the p-values within the primary
study only, therefore it holds for any form of dependence among the p-values within
the follow-up study. In particular, (A.3) holds under the dependency of Theorem
G.1, establishing an upper bound for the first term of the sum in (A.1). It follows
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from Lemma F.1, item 2, that the second term of the sum in (A.1) is bounded by q2.
Thus we obtain:
FDR ≤ |I0|q1
m
+ q2 =
|I0|q1
m
+ q − q1 ≤ q.
Theorem G.2. Assume that the p-values across studies are independent. Then Pro-
cedure 3.2 with parameters (q1, q) controls the FDR at level q for the family of no
replicability null hypotheses HNR,1, . . . , HNR,m if the selection rule used in step 1 of
Procedure 3.2 is a valid selection rule, and the expressions in step 2 of Procedure 3.2
are modified as follows:
1. In the terms r(q−q1)/R1 and R2(q−q1)/R1, q−q1 is replaced by (q−q1)/(
∑R1
i=1 1/i),
and in the terms rq1/m and R2q1/m, q1 is replaced by q1/(
∑m
i=1 1/i).
2. In the terms r(q−q1)/R1 and R2(q−q1)/R1, q−q1 is replaced by (q−q1)/(
∑R1
i=1 1/i),
and in the terms rq1/m and R2q1/m, q1 is replaced by q˜1, where
q˜1 = max{x : x(1 +
⌈tm/x−1⌉∑
i=1
1/i) = q1},
if only hypotheses with primary study p-values at most a fixed threshold t <
q1/(1 +
∑m−1
i=1 1/i) are considered for follow-up, i.e. R1 ⊆ {j ∈ {1, . . . , m} :
P1j ≤ t}.
Proof of item 1. We will first show that the first term of the sum in (A.1) is
bounded by |I0| q1/m. The first term of the sum in (A.1) equals to:
E
( ∑
j∈I0
Rj
max(R, 1)
)
=
∑
j∈I0
m∑
r=1
1
r
Pr
(
j ∈ R1, P1j ≤ rq1
m
∑m
s=1
1
s
, P2j ≤ r(q − q1)|R1|
∑|R1|
s=1 1/s
, C(j)r
)
≤
∑
j∈I0
m∑
r=1
1
r
Pr
(
P1j ≤ rq1
m
∑m
s=1
1
s
, C(j)r
)
.
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Now it follows from the arguments that lead from (F.3) to (F.8) that the first term
of the sum in (A.1) is bounded by |I0| q1/m.
Let us now find an upper bound for the second term of the sum in (A.1). For each
p1, j ∈ R1(p1) ∩ I10, r ∈ {1, . . . , R1(p1)} and l ∈ {1, . . . , R1(p1)}, let us define:
pjrl(p1) = Pr
(
P2j ∈
(
(l − 1)q2
R1(p1)
∑R1(p1)
s=1 1/s
,
lq2
R1(p1)
∑R1(p1)
s=1 1/s
]
, C(j)r
∣∣∣P1 = p1
)
.
(G.1)
Note that for each p1, j ∈ R1(p1) ∩ I10 and l ∈ {1, . . . , R1(p1)}:
R1(p1)∑
r=1
pjrl(p1) = Pr
(
∪R1(p1)r=1 C(j)r , P2j ∈
(
(l − 1)q2
R1(p1)
∑R1(p1)
s=1 1/s
,
lq2
R1(p1)
∑R1(p1)
s=1 1/s
] ∣∣∣P1 = p1
)
= Pr
(
P2j ∈
[
(l − 1)q2
R1(p1)
∑R1(p1)
s=1 1/s
,
lq2
R1(p1)
∑R1(p1)
s=1 1/s
] ∣∣∣P1 = p1
)
.
(G.2)
The equalities follow from the fact that given P1 = p1, ∪R1(p1)r=1 C(j)r is the whole sample
space for P
(j)
2 , represented as a union of disjoint events. In addition, note that for
each p1, j ∈ R1(p1) ∩ I10 and r ∈ {1, . . . , R1(p1)},
Pr
(
P2j ≤ rq2
R1(p1)
∑R1(p1)
s=1 1/s
, C(j)r |P1 = p1
)
=
r∑
l=1
pjrl(p1), (G.3)
since for j ∈ I10, Pr(P2j ≤ x) ≤ x for all x ≥ 0, in particular Pr(P2j = 0) = 0.
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Therefore, for each p1,
E
(∑
j∈I10
Rj/max(R, 1) |P1 = p1
)
=
∑
j∈I10∩R1(p1)
R1(p1)∑
r=1
1
r
I
[
p1j ≤ rq1
m
∑m
s=1 1/s
]
Pr
(
P2j ≤ rq2
R1(p1)
∑R1(p1)
s=1 1/s
, C(j)r |P1 = p1
)
≤
∑
j∈I10∩R1(p1)
R1(p1)∑
r=1
r∑
l=1
1
r
pjrl(p1) =
∑
j∈I10∩R1(p1)
R1(p1)∑
l=1
R1(p1)∑
r=l
1
r
pjrl(p1) (G.4)
≤
∑
j∈I10∩R1(p1)
R1(p1)∑
l=1
R1(p1)∑
r=l
1
l
pjrl(p1) ≤
∑
j∈I10∩R1(p1)
R1(p1)∑
l=1
1
l
R1(p1)∑
r=1
pjrl(p1)
=
∑
j∈I10∩R1(p1)
R1(p1)∑
l=1
1
l
Pr
(
P2j ∈
(
(l − 1)q2
R1(p1)
∑R1(p1)
s=1 1/s
,
lq2
R1(p1)
∑R1(p1)
s=1 1/s
] ∣∣∣P1 = p1
)
=
∑
j∈I10∩R1(p1)
R1(p1)∑
l=1
1
l
Pr
(
P2j ∈
(
(l − 1)q2
R1(p1)
∑R1(p1)
s=1 1/s
,
lq2
R1(p1)
∑R1(p1)
s=1 1/s
])
, (G.5)
where the first inequality in (G.4) follows from (G.3), the next to last equality follows
from (G.2), and the equality in (G.5) follows from the independence of the p-values
across the studies. Using similar arguments to those leading to (F.7), we obtain:
R1(p1)∑
l=1
1
l
Pr
(
P2j ∈
(
(l − 1)q2
R1(p1)
∑R1(p1)
s=1 1/s
,
lq2
R1(p1)
∑R1(p1)
s=1 1/s
])
≤ q2
R1(p1)
.
Combining this result with (G.5) we obtain for each p1:
E
(∑
j∈I10
Rj/max(R, 1) |P1 = p1
)
≤
∑
j∈I10∩R1(p1)
q2
R1(p1)
=
|I10 ∩ R1(p1)|
R1(p1)
q2 ≤ q2.
It follows that
E
(∑
j∈I10
Rj/max(R, 1)
)
≤ q2. (G.6)
Using this fact and the upper bound for the first term of the sum in (A.1), we obtain
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that FDR ≤ |I0|q1/m+ q2 = |I0|q1/m+ q − q1 ≤ q.
Proof of item 2. The first term of the sum in (A.1) equals to:
E
( ∑
j∈I0
Rj
max(R, 1)
)
=
∑
j∈I0
m∑
r=1
1
r
Pr
(
j ∈ R1, P1j ≤ rq˜1
m
,P2j ≤ r(q − q1)|R1|
∑|R1|
s=1 1/s
, C(j)r
)
≤
∑
j∈I0
m∑
r=1
1
r
Pr
(
P1j ≤ min
(
rq˜1
m
, t
)
, C(j)r
)
.
Now it follows from the arguments that lead from (F.9) to (F.18) that the upper
bound for the first term of the sum in (A.1) is q1.
The second term of the sum in (A.1) is E
(∑
j∈I10
Rj/max(R, 1)
)
. For each p1,
E
(∑
j∈I10
Rj/max(R, 1) |P1 = p1
)
=
∑
j∈I10∩R1(p1)
R1(p1)∑
r=1
1
r
I
[
p1j ≤ rq˜1
m
]
Pr
(
P2j ≤ rq2
R1(p1)
∑R1(p1)
s=1 1/s
, C(j)r |P1 = p1
)
≤
∑
j∈I10∩R1(p1)
R1(p1)∑
r=1
r∑
l=1
1
r
pjrl(p1),
where pjrl(p1) is defined in (G.1). Now it follows from the arguments that lead from
(G.4) to (G.6) that the second term of the sum in (A.1) is bounded by q2. Therefore,
FDR ≤ q1 + q2 = q1 + q − q1 = q.
Consider now a situation where both studies are available before the analysis, as
described in Section 4 of the main manuscript. Without loss of generality, we label
the studies as study one and study two.
Theorem G.3. Assume the p-values across studies are independent. Procedure 4.1
with parameters (w1, q1, q) controls the FDR at level q for the family of no replicability
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null hypotheses HNR,1, . . . , HNR,m in either one of the following situations:
1. The set of p-values within each study has property PRDS, and the selection rule
in step 1 of Procedure 3.2 is Bonferroni at level w1q1 when the primary study
is study one, and at level (1− w1)q1 when the primary study is study two.
2. Arbitrary dependence among the p-values within each study, and the expressions
in step 2 of Procedure 3.2 are modified as follows: in the terms rq1/m and
R2q1/R1, q1 is replaced by q1/(
∑m
i=1 1/i), and in the terms r(q − q1)/R1 and
R2(q − q1)/R1, q − q1 is replaced by (q − q1)/(
∑R1
i=1 1/i).
Proof. The proof of Theorem 4.1 in Appendix C relies only on the facts that Procedure
3.2 used in step 1 and in step 2 of Procedure 4.1 is valid. Therefore, the same proof
shows that item 1 follows from item 2 of Theorem 3.3, and item 2 follows from item
1 of Theorem G.2.
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